Papers reviewed not cited S-Z

Salinas GD, Williamson JC, Kalhan R, Thomashow B, Scheckermann JL, Walsh J, Abdolrasulnia M, Foster JA. Barriers to adherence to chronic obstructive pulmonary disease guidelines by primary care physicians. International Journal of COPD 2011:6 171–179

Salman GF, Mosier MC, Beasley BW, Calkins DR. Rehabilitation for patients with Chronic Obstructive Pulmonary Disease: Meta-analysis of Randomized Controlled Trials. J Gen Intern Med 2003; 18: 213-221

Salpeter SR, Buckley NS. Systematic review of clinical outcomes in chronic obstructive pulmonary disease: beta-agonist use compared with anticholinergics and inhaled corticosteroids. Clin Rev Allergy Immunol 2006;31(2-3):219-30

Sampablo I, Carone M, Antoniu SA. Tiotropium therapy and mortality risk in COPD patients: the most severe, the most protected? Evaluation of Celli B, Decramer M, Kesten S, et al. Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009; 180(10): 948-55.

Sandland CJ, Morgan MD, Singh SJ. Patterns of domestic activity and ambulatory oxygen usage in COPD. Chest. 2008 Oct;134(4):753-60

Santiworakul A, Jarungjitaree S, Jalayondeja W, Chantarothorn S, Supaibulpipat S. Effect of lower extremity exercise on muscle strength and physical capacity in COPD patients. J Med Assoc Thai. 2009 Apr;92(4):556-63

Sasaki T, Nakayama K, Yasuda H, Yoshida M, Asamura T, Ohrui T, Arai H, Araya J, Kuwano K, Yamaya M. A randomized, single-blind study of lansoprazole for the prevention of exacerbations of chronic obstructive pulmonary disease in older patients. J Am Geriatr Soc. 2009 Aug;57(8):1453-7.

Sava F, Laviolette L, Bernard S, Breton M-J, Bourbeau J, Maltais F. The impact of obesity on walking and cycling performance and response to pulmonary rehabilitation in COPD. BMC Pulmonary Medicine 2010, 10:55 doi:10.1186/1471-2466-10-55

Scala R, Naldi M, Maccari U. Early fiberoptic bronchoscopy during non-invasive ventilation in patients with decompensated chronic obstructive pulmonary disease due to community-acquired-pneumonia. Critical Care 2010, 14:R80

Schembri S, Morant S, Winter JH, MacDonald TM. Influenza but not pneumococcal vaccination protects against all-cause mortality in patients with COPD. Thorax. 2009 Jul;64(7):567-72

Schenkein JG, Nahm MH, Dransfield MT. Pneumococcal Vaccination for Patients With COPD: Current Practice and Future Directions. Chest 2008;133:767–774

Scher DL, Arsura EL. Multifocal atrial tachycardia: mechanisms, clinical correlates, and treatment. Am Heart J 1989 Sep;118(3):574-80

Schermer TRJ & Quanjer PH. COPD screening in primary care: who is sick? Primary Care Respiratory Journal 2007;16(1):49-53

Schermer T, Leenders J, Veen H, van den Bosch W, Wissink A, Smeele I, Chavannes N. Pulse oximetry in family practice: indications and clinical observations in patients with COPD. Fam Pract. 2009 Dec;26(6):524-31

Schuetz P, Christ-Crain M, Schild U, Süess E, Facompre M, Baty F, Nusbaumer C, Brutsche M, Müller B. Effect of a 14-day course of systemic corticosteroids on the hypothalamicpituitary-adrenal-axis in patients with acute exacerbation of chronic obstructive pulmonary disease. BMC Pulmonary Medicine 2008, 8:1 doi:10.1186/1471-2466-8-1

Schunemann HJ, Puhan M, Goldstein R, Jaeschke R, Guyatt GH. Measurement properties and interpretability of the Chronic respiratory disease questionnaire (CRQ). COPD 2005;2(1):81-9

Sciurba FC, Ernst A, Herth FJF, Strange C, Criner GJ, Marquette CH, Kovitz KL, Chiacchierini RP, Goldin J, McLennan G for the VENT Study Research Group. A randomized study of Endobronchial valves for advanced emphysema. N Engl J Med 2010;363:1233-44

Shahab L, Jarvis MJ, Britton J, West R. Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax 2006;61;1043-104

Sharma G, Kuo YF, Freeman JL, Zhang DD, Goodwin JS. Outpatient follow-up visit and 30-day emergency department visit and readmission in patients hospitalized for chronic obstructive pulmonary disease. Arch Intern Med. 2010 Oct 11;170(18):1664-70

Shea SD, Taylor NF, Paratz J. Peripheral muscle strength training in COPD: a systematic review. Chest 2004;126(3): 903-914

Sin DD, McAlister FA, Man SFP, Anthonisen NR. Contemporary management of chronic obstructive pulmonary disease. JAMA 2003;290(17):2301-2312

Singh S, Loke YK, Enright PL, Furberg CD. Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials. Cite this as: BMJ 2011;342:d3215doi:10.1136/bmj.d3215

Slatore CG, Cecere LM, Reinke LF, Ganzini L, Udris EM, Moss BR, Bryson CL, Curtis JR, Au DH. Patient-clinician communication: associations with important health outcomes among veterans with COPD. Chest. 2010 Sep;138(3):628-34.

Smith V, Devane D, Begley CM, Clarke M. Methodology in conducting a systematic review of systematic reviews of healthcare interventions. BMC Medical Research Methodology 2011, 11:15

Smith-Sivertsen T and Rortveit G. Should general practitioners screen smokers for COPD. Scand J Prim Health Care 2004;22:196-201

Snyder ML, Goss CH, Neradilek B, Polissar NL, Mosenifar Z, Wise RA, Fishman AP, Benditt JO; National Emphysema Treatment Trial Research Group. Changes in arterial oxygenation and self-reported oxygen use after lung volume reduction surgery. Am J Respir Crit Care Med. 2008 Aug 15;178(4):339-45

Sobieraj DM, White CM, Coleman CI. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis. Clin Ther. 2008 Aug;30(8):1416-25

Sorensen L et al. Medication reviews in the community: results of a randomised controlled effectiveness trial. British Journal of Clinical Pharmacology 2004;58(6):648-664

Sridhar M, Taylor R, Dawson S, Roberts NJ, Partridge MR. A nurse led intermediate care package in patients who have been hospitalised with an acute exacerbation of chronic obstructive pulmonary disease. Thorax. 2008 Mar;63(3):194-200

Stav D, Raz M, Shpirer I. Three years of pulmonary rehabilitation: inhibit the decline in airflow obstruction, improves exercise endurance time, and body-mass index, in chronic obstructive pulmonary disease. BMC Pulm Med. 2009 May 30;9:26

Steurer-Stey C, Bachmann LM, Steurer J, Tramer MR. Oral purified bacterial extracts in chronic bronchitis and COPD: systematic review. Chest 2004; 126(5): 1645-1655

Stockley RA, Whitehead PJ, Williams MK. Improved outcomes in patients with chronic obstructive pulmonary disease treated with salmeterol compared with placebo/ usual therapy: results of a meta-analysis. Respiratory Research 2006;7:147

Strange et al. Design of the Endobronchial Valve for Emphysema Palliation Trial (VENT): a non-surgical method of lung volume reduction. BMC Pulmonary Medicine 2007, 7:10

Strong M, South G, Carlisle R. The UK Quality and Outcomes Framework pay-for-performance scheme and spirometry: rewarding quality or just quantity? A cross-sectional study in Rotherham, UK. BMC Health Serv Res. 2009 Jun 28;9:108

Sutherland E Rand. Inhaled steroids and outcomes in COPD: Progressing beyond FEV₁. Chest 2007;131(3):648-649

Ta M, Johnson G. Management of COPD in Australia after the publication of national guidelines. Internal Medicine Journal 2009 doi: 10.1111/j.1445-5994.2009.02133

Tanabe N, Muro S, Hirai T, Oguma T, Terada T, Marumo S, Kinose D, Ogawa E, Hoshino Y, Mishima M. Impact of Exacerbations on Emphysema Progression in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2011;183:1653-1659

Thomas MJ, Simpson J, Riley R, Grant E. The impact of home-based physiotherapy interventions on breathlessness during activities of daily living in severe COPD: a systematic review. Physiotherapy. 2010 Jun;96(2):108-19

Tierney WM et al. Can computer-generated evidence-based care suggestions enhance evidence-based management of asthma and chronic obstructive pulmonary disease? A randomized, controlled trial. Health Serv Res. 2005 Apr;40(2): 477-97

Tinkelman DG, Price DB, Nordyke RJ, Halbert RJ, Isonaka S, Nonikov D, Juniper EF, Freeman D, Hausen T, Levy ML, Ostrem A, van der Molen T, van Schayck CP. Symptom-based questionnaire for differentiating COPD and asthma. Respiration 2006;73(3):296-305

Toljamo T, Kaukonen M, Nieminen P, Kinnula VL. Early detection of COPD combined with individualized counselling for smoking cessation: a two-year prospective study. Scand J Prim Health Care. 2010 Mar;28(1):41-6

Trappenburg JC, van Deventer AC, Troosters T, Verheij TJ, Schrijvers AJ, Lammers JW, Monninkhof EM. The impact of using different symptom-based exacerbation algorithms in patients with COPD. Eur Respir J. 2011 May;37(5):1260-8

Troosters T, Probst VS, Crul T, Pitta F, Gayan-Ramirez G, Decramer M, Gosselink R. Resistance training prevents deterioration in quadriceps muscle function during acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010 May 15;181(10):1072-7

University of York Cochrane Centre for Reviews, Dissemination. Inhaler devices for the management of asthma and COPD. Effective Health Care 2003;8(1):1-12

Uronis HE, Currow DC, Abernethy AP. Palliative management of refractory dyspnea in COPD. Int J Chron Obstruct Pulmon Dis. 2006;1(3):289-304

Uronis H, McCrory DC, Samsa G, Currow D, Abernethy A. Symptomatic oxygen for non-hypoxaemic chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews: Reviews 2011 Issue 6 John Wiley & Sons, Ltd Chichester, UK DOI: 10.1002/14651858.CD006429.pub2

Usmani ZA, Carson KV, Cheng JN, Esterman AJ, Smith BJ. Pharmacological interventions for the treatment of anxiety disorders in chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2011, Issue 11. Art. No.: CD008483. DOI: 10.1002/14651858.CD008483.pub2 

van den Bemt L, Schermer TR, Smeele IJ, Boonman-de Winter LJ, van Boxem T, Denis J, Grootens-Stekelenburg JG, Grol RP, van Weel C. An expert-supported monitoring system for patients with chronic obstructive pulmonary disease in general practice: results of a cluster randomised controlled trial. Med J Aust. 2009 Sep 7;191(5):249-54

van Helvoort HA, de Boer RC, van de Broek L, Dekhuijzen R, Heijdra YF. Exercises commonly used in rehabilitation of patients with chronic obstructive pulmonary disease: cardiopulmonary responses and effect over time. Arch Phys Med Rehabil. 2011 Jan;92(1):111-7

van Noord JA, Buhl R, Laforce C, Martin C, Jones F, Dolker M, Overend T. QVA149 demonstrates superior bronchodilation compared with indacaterol or placebo in patients with chronic obstructive pulmonary disease. Thorax. 2010 Dec;65(12):1086-91

van Wetering CR, Hoogendoorn M, Mol SJM, Rutten-van Mo¨lken MPMH, Schols AM. Short- and long-term efficacy of a community-based COPD management programme in less advanced COPD: a randomised controlled trial. Thorax 2010;65:7–13

Varma-Basil M, Dwivedi SK, Kumar K, Pathak R, Rastogi R, Thukral SS, Shariff M, Vijayan VK, Chhabra SK, Chaudhary R. Role of Mycoplasma pneumoniae infection in acute exacerbations of chronic obstructive pulmonary disease. J Med Microbiol. 2009 Mar;58(Pt 3):322-6

Vestbo J, Pauwels R, Anderson JA, Jones P, Calverley P, TRISTAN study group. Early onset of effect of salmeterol and fluticasone propionate in chronic obstructive pulmonary disease. Thorax 2005;60(4):301-4

Vestbo J, Edwards LD, Scanlon PD, Yates JC, Agusti A, Bakke P, Calverley PM, Celli B, Coxson HO, Crim C, Lomas DA, MacNee W, Miller BE, Silverman EK, Tal-Singer R, Wouters E, Rennard SI; ECLIPSE Investigators. Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med. 2011 Sep 29;365(13):1184-92

Vestbo J, Soriano JB, Anderson JA, Calverley P, Pauwels R, Jones P, TRISTAN Study Group. Gender does not influence the response to the combination of salmeterol and fluticasone propionate in COPD. 2004

Vitry AI and Zhang Y. Quality of Australian clinical guidelines and relevance to the care of older people with multiple comorbid conditions. MJA 2008; 189: 360–365

Wakabayashi R, Motegi T, Yamada K, Ishii T, Gemma A, Kida K. Presence of in-home caregiver and health outcomes of older adults with chronic obstructive pulmonary disease. J Am Geriatr Soc. 2011 Jan;59(1):44-9. doi: 10.1111/j.1532-5415.2010.03222.x

Walker PP, Burnett A, Flavahan PW, Calverley PM. Lower limb activity and its determinants in COPD. Thorax. 2008 Aug;63(8):683-9

Walters JA, Hansen EC, Johns DP, Blizzard EL, Walters EH, Wood-Baker R. A mixed methods study to compare models of spirometry delivery in primary care for patients at risk of COPD. Thorax. 2008 May;63(5):408-14. Epub 2007 Nov 16

Watz H, Waschki B, Kirsten A, Müller KC, Kretschmar G, Meyer T, Holz O, Magnussen H. The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivity. Chest. 2009 Oct;136(4):1039-46

Wedzicha JA, Seemungal TAR. Inhaled corticosteroids in COPD: a light at the end of the tunnel? Thorax 2005;60:977-978

Wedzicha JA. Collaboration in inhaled steroids in COPD. Thorax 2005;60:977

West R and Zhou X. Is nicotine replacement therapy for smoking cessation effective in the ‘‘real world’’? Findings from a prospective multinational cohort study. Thorax 2007;62:998–1002

Westwood M, Bourbeau J, Jones PW, Cerulli A, Capkun-Niggli G, Worthy G. Relationship between FEV₁ change and patient-reported outcomes in randomised trials of inhaled bronchodilators for stable COPD: a systematic review. Respiratory Research 2011, 12:40 doi:10.1186/1465-9921-12-40

Wijkstra PJ, Lacasse Y, Guyatt GH, Goldstein RS. Nocturnal non-invasive positive pressure ventilation for stable chronic obstructive pulmonary disease. The Cochrane Database of Systematic Reviews 2002, Issue 3. Art. No.: CD002878. DOI: 10.1002/14651858:CD002878

Wilson DH, Tucker G, Frith P, Appleton, S, Ruffin RE, Adams RJ. Trends in hospital admissions and mortality from asthma and chronic obstructive pulmonary disease in Australia 1993-2003. MJA 2007;186:408-411

Williamson PA, Short PM, Clearie KL, Vaidyanathan S, Fardon TC, Howaniec LJ, Lipworth BJ. Paradoxical trough effects of triple therapy with budesonide/formoterol and tiotropium bromide on pulmonary function outcomes in COPD. Chest. 2010 Sep;138(3):595-604.

Wilt TJ, Niewoehner D, MacDonald R, Kane RL. Management of stable chronic obstructive pulmonary disease: a systematic review for a clinical practice guideline. Ann Intern Med. 2007 Nov 6;147(9):639-53

Wong R, Sibley KM, Hudani M, Roeland S, Visconti M, Balsano J, Hill K, Brooks D. Characteristics of people with chronic lung disease who rest during the six-minute walk test. Arch Phys Med Rehabil. 2010 Nov;91(11):1765-9

Wood AM, Harrison RM, Semple S, Ayres JG, Stockley RA. Outdoor air pollution is associated with rapid decline of lung function in alpha-1-antitrypsin deficiency. Occup Environ Med. 2010 Aug;67(8):556-61.

Wood-Baker R, Walters J, Walters EH. Systemic corticosteroids in chronic obstructive pulmonary disease: an overview of Cochrane systematic reviews. Respir Med. 2007 Mar;101(3):371-7. Epub 2006 Sep 7

Worth H, Schacher C, Dethlefsen U. Concomitant therapy with Cineole (Eucalyptole) reduces exacerbations in COPD: A placebo-controlled double-blind trial. Respiratory Research 2009, 10:69 doi:10.1186/1465-9921-10-69

Xuan W, Correll P, Ampon R, Williamson M, Marks G. Time trends in hospitalisations and deaths due to COPD and asthma among persons aged 55 and over, 1997-2003. Australian Centre for Asthma Monitoring & Woolcock Institute of Medical Research (Poster)

Zainuldin R, Mackey MG, Alison JA. Optimal intensity and type of leg exercise training for people with chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2011, Issue 11. Art. No.: CD008008. DOI: 10.1002/14651858.CD008008.pub2

Zaman M, Mahmood S, Altayeh A. Low inspiratory capacity to total lung capacity ratio is a risk factor for chronic obstructive pulmonary disease exacerbation. Am J Med Sci. 2010 May;339(5):411-4

Zanobetti A, Bind MA, Schwartz J. Particulate air pollution and survival in a COPD cohort. Environ Health. 2008 Oct 10;7:48

Zhang X, Waterman LA, Ward J, Baird JC, Mahler DA. Advantages of endurance treadmill walking compared with cycling to assess bronchodilator therapy. Chest. 2010 Jun;137(6):1354-61

Zhou Y, Hu G, Wang D, Wang S, Wang Y, Liu Z, Hu J, Shi Z, Peng G, Liu S, Lu J, Zheng J, Wang J, Zhong N, Ran P. Community based integrated intervention for prevention and management of chronic obstructive pulmonary disease (COPD) in Guangdong, China: cluster randomized controlled trial. BMJ. 2010 Dec 1;341:c6387. doi: 10.1136/bmj.c6387

Zwar N et al. A cluster randomised controlled trial of nurse and GP partnership for care of Chronic Obstructive Pulmonary Disease. BMC Pulmonary Medicine 2008, 8:8

< Prev		Next >